麻豆国产精品一二三在线观-麻豆国产精品一二三在线观看-麻豆国产精品一区二区-麻豆国产精品永久免费视频-麻豆国产巨作av剧情-麻豆国产蜜桃臀视频在线观看

諾賽基因
北京諾賽基因組研究中心有限公司作為中國最大的以基因組學(xué)為基礎(chǔ)的生物科技公司之一，北京諾賽基因組研究中心有限公司成立于1998年9月，由北京生物技術(shù)和新醫(yī)藥產(chǎn)業(yè)促進(jìn)中心與北京博大科技投資開發(fā)有限公司投資，中國醫(yī)學(xué)科學(xué)院/中國協(xié)和醫(yī)科大學(xué)、北京大學(xué)、中國科學(xué)院、軍事醫(yī)學(xué)科學(xué)院等單位參與組建。1998年10月，國家科技部批準(zhǔn)在諾賽基因的基礎(chǔ)上成立國家人類基因組北方研究中心，作為國家級(jí)研究基地。
諾賽基因成功參與了“國際人類基因組計(jì)劃”，隨后完成了一系列重要的基因組研究項(xiàng)目，比如致病微生物全基因組測(cè)序研究項(xiàng)目，中國人群SNP檢測(cè)項(xiàng)目和其它一些疾病基因組學(xué)研究項(xiàng)目。
目前，諾賽基因已經(jīng)從最初的DNA 測(cè)序和基因分析服務(wù)，拓展到整個(gè)分子生物學(xué)和蛋白質(zhì)組學(xué)研究和服務(wù)的廣泛領(lǐng)域。我們已經(jīng)擁有多個(gè)獨(dú)立的、技術(shù)精湛的研究團(tuán)隊(duì)，包括基因組學(xué)、蛋白組學(xué)、抗體組學(xué)和細(xì)胞學(xué)等。更為重要的是，我們擁有一套完善的質(zhì)量管理體系，對(duì)我們的生產(chǎn)和服務(wù)進(jìn)行嚴(yán)格的監(jiān)控。2004年，諾賽基因的質(zhì)量管理體系已經(jīng)通過ISO 9001:2000標(biāo)準(zhǔn)驗(yàn)證。目前，公司正在通過ISO/IEC 17025:2005檢測(cè)標(biāo)準(zhǔn)實(shí)驗(yàn)室能力的認(rèn)證。
諾賽基因位于北京經(jīng)濟(jì)技術(shù)開發(fā)區(qū)，實(shí)驗(yàn)室面積約5000平方米，擁有員工100多名。為從事高通量實(shí)驗(yàn)分析、基因組學(xué)研究和蛋白組學(xué)研究配備了多套高端實(shí)驗(yàn)設(shè)備，包括DNA測(cè)序儀、質(zhì)譜分析儀、高性能液相色譜、微陣列芯片分析儀和實(shí)驗(yàn)室自動(dòng)工作站等。目前，公司已正式運(yùn)行實(shí)驗(yàn)室信息管理系統(tǒng)（Laboratory Information Management System , LIMS），同時(shí)對(duì)樣品、數(shù)據(jù)、工作流和所有的標(biāo)準(zhǔn)操作流程(Standard Operation Procedure, SOP)進(jìn)行標(biāo)準(zhǔn)化管理，達(dá)到提高生產(chǎn)效率、產(chǎn)品質(zhì)量和服務(wù)質(zhì)量的目的，滿足客戶需求。
特別是在最近幾年，諾賽基因已經(jīng)為國內(nèi)和國際上一些醫(yī)院公司成功地提供了各類高質(zhì)高效的服務(wù)。無論是在科學(xué)研究還是在產(chǎn)業(yè)化生產(chǎn)方面，正是我們卓有成效并得到廣泛認(rèn)可的工作成績(jī)，讓我們成為了國內(nèi)外客戶心目中最好的生物技術(shù)服務(wù)公司之一。

As one of the largest genomics-based biotech companies in China, SinoGenoMax Co.,Ltd. was incorporated in September,1998 by a joint investment from the Beijing Municipal Science & Technology Commission and Beijing Boda Sci-Tech Venture Capital Ltd. Its founding members include the Chinese Academy of Medical Sciences,Peking University,Chinese Academy of Science,and Beijing institute of Medical Sciences.The affililated institute,Chinese National Human Genome Center of Beijing (CHGB)was established in October,1998 at SinoGenoMax.

SinoGenoMax participated in the International Human Genome Sequencing Project, and has been closely involved in several major genome-related research projects such as pathogenic microorganism sequencing projects, Chinese population single nucleotide polymorphism (SNP) genotyping project, and other disease genome research projects. Originally focused on DNA sequencing and analysis, SinoGenoMax has subsequently expanded its expertise in all aspects of molecular biology and protein biology. We have built up several independent technical groups including genomics group, proteomics group, molecular biology group. In particular,we have perfected a rigorous quality management system to implement process monitoring and quality control for all the procedures we perform.We have passed ISO 9001:2000 international certification of quality management system since 2004,and now we are preparing to obtain ISO/IEC 17025:2005 accreditation of testing laboratory.

There are currently 100 employees working at SinoGenoMax located in Beijing Economic-Technological Development Area.Our 5,000 square meter laboratory building is fully equipped with top class facilities including DNA Sequencers,mass spectrometry,HPLC,Microarray Chip Reader,and lab automation workstation,for high throughput operation and analysis in genomics and proteomics research.A proprietary Laboratory Information Management System(LIMS) has been implemented for standardized management of samples,data and work flow, and all procedures are performed under the guidance of corresponding SOPs.

In the past few years, SinoGenoMax has successfully provided high quality and cost-effective services for several international pharmaceutical companies.Wether in the scientific reaserch or industrial of production, the widely recognized achievements make us become the best biotechnology service company at home and abroad.